BioCentury
ARTICLE | Company News

Pfenex, Merck deal

December 21, 2009 8:00 AM UTC

Pfenex granted Merck exclusive, worldwide rights to use Pfenex Expression Technology for the production of proteins to be used in an undisclosed vaccine candidate. The companies will collaborate on de...